IOL Chemicals and Pharmaceuticals Share Price

NSE: IOLCP

S Cap

₹ 198.60

+₹10.22 (5.43%)

Last updated 03 Sep, 2026, 09:44 IST

IOL Chemicals and Pharmaceuticals Share Price Today

As of 3 Sep 2026, IOL Chemicals and Pharmaceuticals share price is ₹198.60. The stock opened at ₹189.80, compared to its previous close of ₹188.38. During today's trading session, IOL Chemicals and Pharmaceuticals share price moved in the range of ₹189.70 to ₹202.39, with an average price of ₹196.04 for the day. Looking at its last 52-week, the stock has touched a low of ₹67.19 and a high of ₹202.39. On the performance front, IOL Chemicals and Pharmaceuticals share price has increased by 163.95% over the last six months and is up 97.82% on a year-on-year basis.

₹189.70

5.43% up today

₹202.39

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 22.43% QoQ

Latest Earning

Net Profit TrendUp by 21.14% QoQ

Latest Earning

Revenue TrendUp by 23.04% QoQ

Stock Performance

OutperformingBeat Nifty by 28.46 % in last 1 month

Shareholding Pattern

PromoterPromoter increased stake by 8.35%

Shareholding Pattern

DIIDII increased stake by 11731.43%

Shareholding Pattern

FIIFII increased stake by 183.31%

IOL Chemicals and Pharmaceuticals Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹10,25,642+₹5,25,642 (+105.13%)

3 Year

₹10,42,423+₹5,42,423 (+108.48%)

5 Year

₹8,37,011+₹3,37,011 (+67.40%)

₹150.71₹226.05

Circuit Low

Circuit High

₹67.19₹202.39

52-Week Low

52-Week High

Circuit

₹150.71

₹226.05

52-week

₹67.19

₹202.39

About IOL Chemicals and Pharmaceuticals

ISIN

INE485C01029

Sector Market Cap

₹ 5,590.23 Cr

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.

IOL Chemicals and Pharmaceuticals Financial Highlights

Revenue: IOL Chemicals and Pharmaceuticals reported revenue of ₹2,340.44 crore in FY26 vs ₹2,101.62 crore in FY25. It showed an increase of 11.36% on a yearly basis.
Operating Profit: IOL Chemicals and Pharmaceuticals reported an operating profit of ₹184.36 crore in FY26 vs ₹137.96 crore in FY25. It showed an increase of 33.63% on a year-on-year basis.
Net Profit: IOL Chemicals and Pharmaceuticals reported a net profit of ₹137.64 crore in FY26 vs ₹101.07 crore in FY25. It showed an increase of 36.18% on a yearly basis.

IOL Chemicals and Pharmaceuticals Quarterly Result Highlights

IOL Chemicals and Pharmaceuticals reported revenue of ₹764.44 crore in Jun 2026, compared with ₹621.29 crore in Mar 2026, representing an increase of 23.04% on a quarter-on-quarter (QoQ) basis.
IOL Chemicals and Pharmaceuticals reported an operating profit of ₹86.69 crore in Jun 2026, compared with ₹70.81 crore in Mar 2026, representing an increase of 22.43% on a quarter-on-quarter (QoQ) basis.
IOL Chemicals and Pharmaceuticals reported a profit of ₹64.40 crore in Jun 2026, compared with ₹53.16 crore in Mar 2026, reflecting an increase of 21.14% on a QoQ basis.
The earnings per share (EPS) of IOL Chemicals and Pharmaceuticals stood at ₹4.69 during Jun 2026.

Know more

Promoters

62.28%

FII

4.87%

Other DII

0.41%

Retail and other

32.42%

Mutual funds

0.02%

Foreign institutions - FII

FII shareholding by period
Sep 2025	2.25%
Dec 2025	2.08%
Mar 2026	1.72%
Jun 2026	4.87%

Mkt Cap Cr

5,590.23

P/E

32.86

P/B

3.07

ROE

7.65%

D/E

0.08

ROCE

10.29%

Div. Yield

0.53%

EPS(TTM)

4.69

Turnover

0.98

EV/EBITDA

17.21

Net Margin

5.94%

Op. Margin

12.04%

ROA

6.50%

Quick Ratio

1.24

Curr. Ratio

2.20

Mkt Cap Cr

5,590.23

P/E

32.86

P/B

3.07

ROE

7.65%

D/E

0.08

ROCE

10.29%

Div. Yield

0.53%

EPS(TTM)

4.69

Turnover

0.98

EV/EBITDA

17.21

Net Margin

5.94%

Op. Margin

12.04%

ROA

6.50%

Quick Ratio

1.24

Curr. Ratio

2.20

Based on fundamentals, this stock's

Performance

Excellent

IOL Chemicals outperforming all market indices

Valuation

Overvalued

IOL Chemicals appears overvalued compared to its peers

Earnings

Excellent

IOL Chemicals revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,63,180.00	38.28	5.55	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,43,302.00	83.79	14.62	15.32%	0.00	19.56%	629.49	0.32%	0.55	98.19
Torrent Pharmaceuticals	1,88,623.00	88.29	22.64	25.49%	1.69	13.85%	222.76	0.68%	0.49	58.70
Zydus Lifesciences	1,16,114.00	25.00	4.24	18.59%	0.31	17.35%	237.30	0.09%	0.33	35.38
Cipla	1,14,554.00	34.02	3.32	11.27%	0.00	14.95%	423.36	0.92%	0.45	43.52
Laurus Labs	1,00,660.00	92.32	18.99	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Lupin	98,312.20	17.73	4.38	23.76%	0.04	24.88%	659.00	0.84%	0.57	129.18
Dr. Reddy's Laboratories	96,906.30	30.44	2.55	11.07%	0.18	12.54%	377.95	0.69%	0.41	38.68
Mankind Pharma	97,467.00	47.54	6.03	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Aurobindo Pharma	96,836.10	25.68	2.52	9.25%	0.19	11.76%	394.82	0.24%	0.38	41.58

IOL Chemicals and Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹2,319.06	₹2,079.21	₹2,132.79	₹2,217.11
Other Income	₹21.38	₹22.41	₹30.07	₹25.61
Total Revenue	₹2,340.44	₹2,101.62	₹2,162.86	₹2,242.72
Total Expenses	₹2,144.87	₹1,963.66	₹1,981.21	₹2,054.07
Profit Before Tax	₹184.36	₹137.96	₹181.65	₹188.65
Tax	₹46.72	₹36.89	₹47.22	₹49.51
Profit After Tax	₹137.64	₹101.07	₹134.43	₹139.14
EPS - Basic	₹4.69	₹3.44	₹4.58	₹23.70
EPS - Diluted	₹4.69	₹3.44	₹4.58	₹23.70

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹184.36	₹137.96	₹181.65	₹188.65
Income before WC changes	₹269.40	₹217.81	₹241.47	₹233.06
Change in Assets	-₹83.91	₹25.18	-₹71.66	₹41.30
Change in Liabilities	₹66.69	-₹46.05	₹161.99	-₹104.99
Change in WC	-₹17.22	-₹20.87	₹90.33	-₹63.69
Cash flow from Operations	₹214.32	₹178.62	₹289.78	₹122.27
Cash flow from Investing	-₹198.11	-₹154.18	-₹190.98	-₹120.00
Cash flow from Financing	-₹29.03	₹46.04	-₹92.50	-₹4.11
Total Cash Flow	-₹12.82	₹70.48	₹6.30	-₹1.84
Cash (Start of the year)	₹78.17	₹7.69	₹1.39	₹3.23
Cash (End of the year)	₹65.35	₹78.17	₹7.69	₹1.39

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹1,359.32	₹1,230.73	₹1,124.63	₹1,101.74
Current Assets	₹1,227.63	₹1,151.34	₹1,119.77	₹920.39
Total Assets	₹2,586.95	₹2,382.07	₹2,244.40	₹2,022.13
Current Liabilities	₹690.18	₹609.91	₹560.00	₹456.26
Net Current Asset	₹537.45	₹541.43	₹559.77	₹464.13
Non-Current Liabilities	₹98.22	₹84.50	₹72.89	₹58.15
Equity Capital	₹1,798.55	₹1,687.66	₹1,611.51	₹1,507.72
Total Equity & Liabilities	₹2,586.95	₹2,382.07	₹2,244.40	₹2,022.13

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹2,319.06	₹2,079.21	₹2,132.79	₹2,217.11
Other Income	₹21.28	₹22.40	₹30.07	₹25.57
Total Revenue	₹2,340.34	₹2,101.61	₹2,162.86	₹2,242.68
Total Expenses	₹2,144.69	₹1,963.72	₹1,980.22	₹2,053.19
Profit Before Tax	₹184.44	₹137.89	₹182.64	₹189.49
Tax	₹46.72	₹36.89	₹47.22	₹49.51
Profit After Tax	₹137.72	₹101.00	₹135.42	₹139.98
EPS - Basic	₹4.69	₹3.44	₹4.61	₹23.84
EPS - Diluted	₹4.69	₹3.44	₹4.61	₹23.84

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹184.44	₹137.89	₹182.64	₹189.49
Income before WC changes	₹269.52	₹217.67	₹242.40	₹233.91
Change in Assets	-₹83.79	₹25.18	-₹71.90	₹41.67
Change in Liabilities	₹66.55	-₹45.85	₹161.98	-₹105.34
Change in WC	-₹17.24	-₹20.67	₹90.08	-₹63.67
Cash flow from Operations	₹214.42	₹178.68	₹290.46	₹123.14
Cash flow from Investing	-₹198.12	-₹154.23	-₹191.39	-₹119.19
Cash flow from Financing	-₹29.03	₹46.04	-₹92.50	-₹4.11
Total Cash Flow	-₹12.73	₹70.49	₹6.57	-₹0.16
Cash (Start of the year)	₹78.02	₹7.53	₹0.96	₹1.12
Cash (End of the year)	₹65.29	₹78.02	₹7.53	₹0.96

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹1,359.21	₹1,230.66	₹1,124.49	₹1,101.54
Current Assets	₹1,227.51	₹1,151.12	₹1,119.48	₹919.07
Total Assets	₹2,586.72	₹2,381.78	₹2,243.97	₹2,020.61
Current Liabilities	₹690.12	₹609.87	₹559.75	₹455.91
Net Current Asset	₹537.39	₹541.25	₹559.73	₹463.16
Non-Current Liabilities	₹98.22	₹84.50	₹72.89	₹58.15
Equity Capital	₹1,798.38	₹1,687.41	₹1,611.33	₹1,506.55
Total Equity & Liabilities	₹2,586.72	₹2,381.78	₹2,243.97	₹2,020.61